ID   NACC1_RAT               Reviewed;         514 AA.
AC   O35260;
DT   23-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   24-JUL-2024, entry version 139.
DE   RecName: Full=Nucleus accumbens-associated protein 1;
DE            Short=NAC-1;
DE   AltName: Full=BTB/POZ domain-containing protein 14B;
GN   Name=Nacc1; Synonyms=Btbd14b, Nac1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, DEVELOPMENTAL
RP   STAGE, AND INDUCTION.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=9278521; DOI=10.1523/jneurosci.17-18-06864.1997;
RA   Cha X.-Y., Pierce R.C., Kalivas P.W., Mackler S.A.;
RT   "NAC-1, a rat brain mRNA, is increased in the nucleus accumbens three weeks
RT   after chronic cocaine self-administration.";
RL   J. Neurosci. 17:6864-6871(1997).
RN   [2]
RP   FUNCTION, SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE, AND ALTERNATIVE
RP   SPLICING.
RX   PubMed=11906783; DOI=10.1016/s0306-4522(01)00518-8;
RA   Korutla L., Wang P.J., Lewis D.M., Neustadter J.H., Stromberg M.F.,
RA   Mackler S.A.;
RT   "Differences in expression, actions and cocaine regulation of two isoforms
RT   for the brain transcriptional regulator NAC1.";
RL   Neuroscience 110:421-429(2002).
RN   [3]
RP   FUNCTION, AND INTERACTION WITH HDAC3 AND HDAC4.
RX   PubMed=16033423; DOI=10.1111/j.1471-4159.2005.03206.x;
RA   Korutla L., Wang P.J., Mackler S.A.;
RT   "The POZ/BTB protein NAC1 interacts with two different histone deacetylases
RT   in neuronal-like cultures.";
RL   J. Neurochem. 94:786-793(2005).
RN   [4]
RP   SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT SER-245.
RX   PubMed=16045493; DOI=10.1111/j.1460-9568.2005.04208.x;
RA   Korutla L., Champtiaux N., Shen H.-W., Klugmann M., Kalivas P.W.,
RA   Mackler S.A.;
RT   "Activity-dependent subcellular localization of NAC1.";
RL   Eur. J. Neurosci. 22:397-403(2005).
RN   [5]
RP   FUNCTION, INTERACTION WITH RCOR1, AND MUTAGENESIS OF GLN-23.
RX   PubMed=17254023; DOI=10.1111/j.1471-4159.2006.04387.x;
RA   Korutla L., Degnan R., Wang P., Mackler S.A.;
RT   "NAC1, a cocaine-regulated POZ/BTB protein interacts with CoREST.";
RL   J. Neurochem. 101:611-618(2007).
RN   [6]
RP   FUNCTION, INTERACTION WITH CUL3 AND PSMD7, AND SUBCELLULAR LOCATION.
RX   PubMed=17699672; DOI=10.1523/jneurosci.1571-07.2007;
RA   Shen H., Korutla L., Champtiaux N., Toda S., LaLumiere R., Vallone J.,
RA   Klugmann M., Blendy J.A., Mackler S.A., Kalivas P.W.;
RT   "NAC1 regulates the recruitment of the proteasome complex into dendritic
RT   spines.";
RL   J. Neurosci. 27:8903-8913(2007).
CC   -!- FUNCTION: Functions as a transcriptional repressor. Isoform 1 is a
CC       stronger transcriptional repressor than isoform 2. Seems to function as
CC       a transcriptional corepressor in neuronal cells through recruitment of
CC       HDAC3 and HDAC4. Contributes to tumor progression, and tumor cell
CC       proliferation and survival. This may be mediated at least in part
CC       through repressing transcriptional activity of GADD45GIP1. Required for
CC       recruiting the proteasome from the nucleus to the cytoplasm and
CC       dendritic spines. {ECO:0000269|PubMed:11906783,
CC       ECO:0000269|PubMed:16033423, ECO:0000269|PubMed:17254023,
CC       ECO:0000269|PubMed:17699672}.
CC   -!- SUBUNIT: Homooligomer; mediated by the BTB domain (By similarity). Both
CC       isoforms interact with HDAC3 and HDAC4. Interacts (via BTB domain) with
CC       CUL3, PSMD7 and RCOR1. {ECO:0000250, ECO:0000269|PubMed:16033423,
CC       ECO:0000269|PubMed:17254023, ECO:0000269|PubMed:17699672}.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Punctate distribution in
CC       nucleus. In differentiated PC12 cells diffusely distributed in the
CC       cytoplasm and is dependent on phosphorylation.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=lNAC1;
CC         IsoId=O35260-1; Sequence=Displayed;
CC       Name=2; Synonyms=sNAC1;
CC         IsoId=O35260-2; Sequence=VSP_022613;
CC   -!- TISSUE SPECIFICITY: Highly expressed in the hippocampus, brain cortex,
CC       cerebellum and brainstem. Expressed in the nucleus accumbens, olfactory
CC       tubercle, the striatum, frontal and parietal cortex and ventral
CC       pallidum. Weakly expressed in the heart, liver, kidney, spleen, testis,
CC       and skeletal muscle. Isoform 2 is expressed in the brain and liver,
CC       less abundantly expressed in the brain than isoform 1.
CC       {ECO:0000269|PubMed:9278521}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in the brain at 16 dpc, 18 dpc, P2, P8
CC       and P90. {ECO:0000269|PubMed:11906783, ECO:0000269|PubMed:9278521}.
CC   -!- INDUCTION: Expression is increased by cocaine, selectively in the
CC       nucleus accumbens. mRNA is present at increased levels in the nucleus
CC       accumbens 3 weeks after withdrawal from cocaine self-administration.
CC       {ECO:0000269|PubMed:9278521}.
CC   -!- PTM: Phosphorylated by protein kinase C (PKC).
CC       {ECO:0000269|PubMed:16045493}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF015911; AAB69864.1; -; mRNA.
DR   RefSeq; NP_599240.1; NM_134413.2. [O35260-1]
DR   RefSeq; XP_008770568.1; XM_008772346.2. [O35260-1]
DR   AlphaFoldDB; O35260; -.
DR   SMR; O35260; -.
DR   BioGRID; 251261; 1.
DR   STRING; 10116.ENSRNOP00000071927; -.
DR   iPTMnet; O35260; -.
DR   PhosphoSitePlus; O35260; -.
DR   jPOST; O35260; -.
DR   PaxDb; 10116-ENSRNOP00000003884; -.
DR   Ensembl; ENSRNOT00000091670.2; ENSRNOP00000071927.2; ENSRNOG00000002864.6. [O35260-2]
DR   GeneID; 171454; -.
DR   KEGG; rno:171454; -.
DR   AGR; RGD:621003; -.
DR   CTD; 112939; -.
DR   RGD; 621003; Nacc1.
DR   VEuPathDB; HostDB:ENSRNOG00000002864; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000159327; -.
DR   InParanoid; O35260; -.
DR   OMA; DMMSMEH; -.
DR   OrthoDB; 5342883at2759; -.
DR   PhylomeDB; O35260; -.
DR   PRO; PR:O35260; -.
DR   Proteomes; UP000002494; Chromosome 19.
DR   Bgee; ENSRNOG00000002864; Expressed in frontal cortex and 19 other cell types or tissues.
DR   GO; GO:0030054; C:cell junction; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   CDD; cd18290; BTB_POZ_BTBD14B_NAC1; 1.
DR   Gene3D; 1.10.10.2590; BEN domain; 1.
DR   InterPro; IPR018379; BEN_domain.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR050457; ZnFinger_BTB_dom_contain.
DR   PANTHER; PTHR46105; AGAP004733-PA; 1.
DR   PANTHER; PTHR46105:SF3; NUCLEUS ACCUMBENS-ASSOCIATED PROTEIN 1; 1.
DR   Pfam; PF10523; BEN; 1.
DR   Pfam; PF00651; BTB; 1.
DR   SMART; SM01025; BEN; 1.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; POZ domain; 1.
DR   PROSITE; PS51457; BEN; 1.
DR   PROSITE; PS50097; BTB; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; Isopeptide bond; Nucleus; Phosphoprotein;
KW   Reference proteome; Repressor; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN           1..514
FT                   /note="Nucleus accumbens-associated protein 1"
FT                   /id="PRO_0000274043"
FT   DOMAIN          30..94
FT                   /note="BTB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00037"
FT   DOMAIN          360..457
FT                   /note="BEN"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00784"
FT   REGION          183..218
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          241..279
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        191..205
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        242..262
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         187
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96RE7"
FT   MOD_RES         245
FT                   /note="Phosphoserine; by PKC"
FT                   /evidence="ECO:0000269|PubMed:16045493"
FT   MOD_RES         492
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7TSZ8"
FT   MOD_RES         496
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7TSZ8"
FT   CROSSLNK        167
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96RE7"
FT   CROSSLNK        167
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96RE7"
FT   CROSSLNK        182
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q96RE7"
FT   CROSSLNK        304
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q96RE7"
FT   CROSSLNK        438
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q96RE7"
FT   CROSSLNK        466
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q96RE7"
FT   CROSSLNK        485
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q96RE7"
FT   VAR_SEQ         275..301
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_022613"
FT   MUTAGEN         23
FT                   /note="Q->L: Abrogates transcriptional repression."
FT                   /evidence="ECO:0000269|PubMed:17254023"
SQ   SEQUENCE   514 AA;  56450 MW;  5980514174B4BFF5 CRC64;
     MAQTLQMEIP NFGNSILECL NEQRLQGLYC DVSVVVKGHA FKAHRAVLAA SSSYFRDLFN
     SSRSAVVELP AAVQPQSFQQ ILTFCYTGRL SMNMGDQFLL IYTAGFLQIQ EIMEKGTEFF
     LKVSSPSCDS QGLHPEEAPS SEPQSPVAQI LGWPACSTPL PLVSRVKTEQ ELDSVQCTPM
     AKRLWDSSQK EAGGSGGNNG SRKMAKFSTP DLAPNRMPQP VSVATATAAV AVVAVGGCVS
     GPSMSERTSP GTSSAYTSDS PSSYHNEEDE EEDAGEEGTD EQYRQICNMY TMYSMLNVGQ
     TVEKVEALPE QVVLESHSRI RVRQDLASLP AELINQIGNR CHPKLYDEGD PSEKLELVTG
     TNVYITRAQL MNCHVSAGTR HKVLLRRLLA SFFDRNTLAN SCGTGIRSST NDPRRKPLDS
     RVLHAVKYYC QNFAPNFKES EMNAIAADMC TNARRVVRKS WLPKTKPLHL VEGDNYSSFI
     SDTGKIEPDM MSMEHSFETA SHDGEAGPSA EVLQ
//
